Eli Lilly and Company (LLY) CEO Dave Ricks on Q2 2022 Results - Earnings Call Transcript

Eli Lilly and Company (NYSE:LLY) Q2 2022 Earnings Conference Call August 4, 2022 9:00 AM ET

Company Participants

Kevin Hern - Vice President of Investor Relations
Dave Ricks - Chair & Chief Executive Officer
Anat Ashkenazi - Chief Financial Officer
Dan Skovronsky - Chief Scientific Officer & Chief Medical Officer
Mike Mason - President of Lilly Diabetes
Ilya Yuffa - President of Lilly International
Jake Van Naarden - Chief Executive Officer, Loxo Oncology, Lilly & President, Lilly Oncology

Conference Call Participants

Geoff Meacham - Bank of America
Chris Schott - JPMorgan
Seamus Fernandez - Guggenheim
Louise Chen - Cantor
Terence Flynn - Morgan Stanley
Steve Scala - Cowen
Andrew Baum - Citi
Kerry Holford - Berenberg
Robin Kinesis - Tuas Securities
Colin Bristow - UBS

Operator

And ladies and gentlemen, thank you for standing by. Welcome to the Lilly Q2 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] And as a reminder, your conference is being recorded.

I would now like to turn the conference over to your host, Kevin Hern, Vice President of Investor Relations. Please go ahead.

Kevin Hern

Thank you. Good morning, everyone and thank you for joining us for Eli Lilly and Company's Q2 2022 earnings call. Apologies for the hour delay. We had some technical issues on AT&T side. So thanks for your patience. I'm Kevin Hern, Vice President of Investor Relations. Joining me on today's call are Dave Ricks, Lilly's Chair and CEO; and nadashKanazi, Chief Financial Officer; Dr. Dan Scabronsky, Chief Scientific and Medical Officer; Anne White, President of Lilly Neuroscience; Bilia Yuffa, President of Lilly International; Jake Van Norden, CEO of Loxo at Lilly; Mike Mason, President of Lilly Diabetes; and Patrick Jansen, President of Lilly Immunology and Lilly U.S.A. We're also joined by Mike Spring ether, Kenzie and Warren Zirki of the Investor Relations